The mainstream media has been busy touting that the COVID-19 experimental vaccines are completely safe and effective. However, that is far from the truth since they are hundreds and thousands of cases documenting the dangers of this vaccine.
They have been countless reports of people who have received the jab who have become seriously injured and in some cases even died.
However, the media does not want to report on that and actually do their jobs as journalists. Instead, they continually praise these unsafe vaccines to everyone as safe and effective while families suffer in silence. These families are not allowed to post on social media or they will be banned, news stations won’t air interviews with people telling their stories, and people are losing their jobs if they question any of it.
How is this is the land of the free and the home of the brave?
Now, it has been revealed in a recent study even more reasons why people are wary to get the shot.
A new study found the Johnson & Johnson COVID-19 vaccine increases the risk of blood clots.
The study was conducted by Mayo Clinic researchers in Rochester, Minnesota. They were specifically looking for cases of a type of blood cot called cerebral venous sinus thrombosis in Olmsted County, Minnesota, and they published their findings in JAMA Internal Medicine.
First, the researchers studied cases of CVST from 2001 to 2015 in Olmstead County. According to the U.K.’s Daily Mail, the county has a population of about 158,000.
Here is more from Western Journal:
Over that 14-year span, the researchers found 39 patients who had developed acute incident CVST. Adjusted for population, that translated to about 2.34 cases per 100,000 person-years.
Of those 39 patients, 29 of them had a pre-existing risk factor within 92 days before developing the blood clot, according to the study. The Daily Mail said those risk factors include things like cancer or infection.
Next, the researchers studied CVST cases from the J&J vaccine’s approval in late February to May 7, 2021. The Daily Mail reported about 8.7 million doses of the vaccine had been given around the country during that time period.
In Olmstead County, the researchers found 46 CVST cases were reported to the Vaccine Adverse Event Reporting System within 92 days of receiving the vaccine. Eight of those were disregarded for various reasons, bringing the total to 38 “objectively diagnosed cases” of CVST.
At 15 days after vaccination, the researchers found 8.65 cases per 100,000 person-years. That rate is 3.7 times higher than the rate researchers found during their 14-year analysis of the general population.
In female patients, in particular, the rate was 13.01 cases per 100,000 person-years. The study said the CVST case rate was 5.1 times higher after vaccination among just female individuals compared to the pre-pandemic rate.
Overall, the researchers said their study found the CVST incidence rate within 15 days of receiving the J&J vaccine was “significantly higher than the prepandemic rate.”
To the average American, that should be concerning. While correlation does not necessarily equal causation, it certainly appears that the J&J vaccine may increase the risk of blood clots.
“[T]he higher rate of this rare adverse effect must be considered in the context of the effectiveness of the vaccine in preventing COVID-19,” the researchers said in the discussion portion of the study.
That may very well be true, but it does not change the fact that a higher risk of CVST does appear to be present post-vaccination. Americans have a right to choose for themselves which risk they want to take, and deserve to have the full information presented to them.
If a person is not vaccinated, they run the risk of getting COVID-19 and possibly more severe symptoms. If they are vaccinated, they face the risk of adverse effects like blood clots.